Results 291 to 300 of about 1,855,857 (359)
Effects of curcumin on metabolic and systemic diseases: Narrative review
Wendy Fiorella Cruz-Bacilio +4 more
openalex +2 more sources
Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer +14 more
wiley +1 more source
Preclinical research in obesity-associated metabolic diseases using in vitro, multicellular, and non-mammalian models. [PDF]
Aranaz P +18 more
europepmc +1 more source
Adipose Tissue Dysfunction and Metabolic Diseases: The Role of Vitamin D/Vitamin D Receptor Axis. [PDF]
Cimini FA +4 more
europepmc +1 more source
Global, regional and national burden of asthma attributable to metabolic diseases from 1990 to 2021 and projected trends to 2040. [PDF]
Zhang ZQ +10 more
europepmc +1 more source
Survodutide: a novel peptide for treatment of obesity and metabolic diseases. [PDF]
Vinton TY.
europepmc +1 more source

